Bruker Financial Activities - Other 2010-2025 | BRKR

Bruker annual/quarterly financial activities - other history and growth rate from 2010 to 2025. Financial activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the financing activities section of the Cash Flows Statement.
  • Bruker financial activities - other for the quarter ending March 31, 2025 was $-0.001B, a 80.36% decline year-over-year.
  • Bruker financial activities - other for the twelve months ending March 31, 2025 was $-0.068B, a 402.96% increase year-over-year.
  • Bruker annual financial activities - other for 2024 was $-0.025B, a 8400% decline from 2023.
  • Bruker annual financial activities - other for 2023 was $0B, a 102.07% decline from 2022.
  • Bruker annual financial activities - other for 2022 was $-0.015B, a 2800% increase from 2021.
Bruker Annual Financial Activities - Other
(Millions of US $)
2024 $-25
2023 $0
2022 $-15
2021 $-1
2020 $-10
2019 $-11
2018 $-3
2017 $-29
2016 $-25
2015 $-1
2014 $0
2013 $0
2012 $-3
2011 $-1
2010 $-1
2009 $-1
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $5.728B $3.366B
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
Stock Name Country Market Cap PE Ratio
Kewaunee Scientific (KEQU) United States $0.105B 7.41
Harvard Bioscience (HBIO) United States $0.015B 0.00